For a listing of the new molecular entity U.S. launches during 2013, please click on the link below: NME 2013 Launches Online 0815
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals has launched four new products since June 2015. On July 13, the company obtained FDA approval for its tobramycin inhalation solution (a generic equivalent for Tobi® […]
R&D efforts on the part of major biopharmaceutical companies for novel drugs to treat depression and other CNS diseases have eroded over the past decade. In fact, a study published […]
MIAMI–(BUSINESS WIRE)–Nicofi™ announced the launch of a revolutionary patented, fast-acting dissolvable nicotine tablet intended for use as an alternative to smoking. Nicofi is a small sublingual tablet made from pure […]
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the launch of the generic equivalent to INTUNIV® (guanfacine) 1 mg, 2 mg, 3 mg, and 4 mg, in the United States. […]
CINCINNATI–(BUSINESS WIRE)–Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received the CE Mark for new molecular assays for the detection of Herpes Simplex Virus Type 1 (HSV-1) and […]
BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. today announced the launch of GeneStrat™, a targeted liquid biopsy mutation test for genotyping tumors of patients with advanced non-small cell lung cancer (NSCLC). The blood […]
MADISON, N.J.–(BUSINESS WIRE)–Pfizer Consumer Healthcare, the makers of America’s most-preferred and most-clinically studied multivitamin brand, Centrum®, has announced the launch of Centrum® MultiGummies, a great-tasting, easy-to-take multivitamin, specifically designed with […]
